Issue navigation
Volume 73, Issue 2, February 2018
Reviews
Metronidazole: an update on metabolism, structure–cytotoxicity and resistance mechanisms
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 265–279, https://doi.org/10.1093/jac/dkx351
A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 280–286, https://doi.org/10.1093/jac/dkx390
Systematic reviews
Association between prior antibiotic therapy and subsequent risk of community-acquired infections: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 287–296, https://doi.org/10.1093/jac/dkx374
A systematic review of interventions and performance measures for antifungal stewardship programmes
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 297–305, https://doi.org/10.1093/jac/dkx388
Original research
Distribution of putative virulence markers in Enterococcus faecium: towards a safety profile review
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 306–319, https://doi.org/10.1093/jac/dkx387
Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 320–324, https://doi.org/10.1093/jac/dkx400
Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 325–331, https://doi.org/10.1093/jac/dkx372
Mutations in MetG (methionyl-tRNA synthetase) and TrmD [tRNA (guanine-N1)-methyltransferase] conferring meropenem tolerance in Burkholderia thailandensis
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 332–338, https://doi.org/10.1093/jac/dkx378
Molecular relatedness of ESBL/AmpC-producing Escherichia coli from humans, animals, food and the environment: a pooled analysis
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 339–347, https://doi.org/10.1093/jac/dkx397
Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 348–352, https://doi.org/10.1093/jac/dkx375
Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 353–364, https://doi.org/10.1093/jac/dkx405
Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 365–372, https://doi.org/10.1093/jac/dkx379
Origin of the plasmid-mediated fosfomycin resistance gene fosA3
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 373–376, https://doi.org/10.1093/jac/dkx389
Increase in antimicrobial resistance and emergence of major international high-risk clonal lineages in dogs and cats with urinary tract infection: 16 year retrospective study
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 377–384, https://doi.org/10.1093/jac/dkx401
Rapid disc diffusion antibiotic susceptibility testing for Pseudomonas aeruginosa, Acinetobacter baumannii and Enterococcus spp.
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 385–391, https://doi.org/10.1093/jac/dkx404
Miltefosine-resistant Leishmania infantum strains with an impaired MT/ROS3 transporter complex retain amphotericin B susceptibility
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 392–394, https://doi.org/10.1093/jac/dkx407
Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 395–403, https://doi.org/10.1093/jac/dkx412
Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 404–408, https://doi.org/10.1093/jac/dkx410
Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 409–413, https://doi.org/10.1093/jac/dkx392
Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 414–424, https://doi.org/10.1093/jac/dkx395
Bacterial zincophore [S,S]-ethylenediamine-N,N′-disuccinic acid is an effective inhibitor of MBLs
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 425–430, https://doi.org/10.1093/jac/dkx403
In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 431–436, https://doi.org/10.1093/jac/dkx419
A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 437–447, https://doi.org/10.1093/jac/dkx380
Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 448–451, https://doi.org/10.1093/jac/dkx422
Polymyxin derivatives NAB739 and NAB815 are more effective than polymyxin B in murine Escherichia coli pyelonephritis
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 452–455, https://doi.org/10.1093/jac/dkx394
Activity of colistin alone or in combination with rifampicin or meropenem in a carbapenem-resistant bioluminescent Pseudomonas aeruginosa intraperitoneal murine infection model
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 456–461, https://doi.org/10.1093/jac/dkx399
Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 462–468, https://doi.org/10.1093/jac/dkx409
Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 469–476, https://doi.org/10.1093/jac/dkx376
Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 477–483, https://doi.org/10.1093/jac/dkx421
CNS penetration of ART in HIV-infected children
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 484–489, https://doi.org/10.1093/jac/dkx396
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 490–493, https://doi.org/10.1093/jac/dkx417
Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 494–502, https://doi.org/10.1093/jac/dkx391
Interim outcomes of delamanid for the treatment of MDR- and XDR-TB in South Korea
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 503–508, https://doi.org/10.1093/jac/dkx373
Utilization of a clinical microbiology service at a Cambodian paediatric hospital and its impact on appropriate antimicrobial prescribing
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 509–516, https://doi.org/10.1093/jac/dkx414
Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 517–526, https://doi.org/10.1093/jac/dkx413
Impact of requiring re-authorization of restricted antibiotics on day 3 of therapy
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 527–530, https://doi.org/10.1093/jac/dkx384
Research letters
Complete nucleotide sequences of two KPC-2-encoding plasmids from the same Citrobacter freundii isolate
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 531–533, https://doi.org/10.1093/jac/dkx381
Epidemic spread of Escherichia coli ST744 isolates carrying mcr-3 and blaCTX-M-55 in cattle in France
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 533–536, https://doi.org/10.1093/jac/dkx418
Identification and genomic characterization of a KPC-2-, NDM-1- and NDM-5-producing Klebsiella michiganensis isolate
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 536–538, https://doi.org/10.1093/jac/dkx415
Evaluation of the KPC K-SeT® immunochromatographic assay for the rapid detection of KPC carbapenemase producers from positive blood cultures
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 539–540, https://doi.org/10.1093/jac/dkx406
Antibiotic susceptibility of clinical Legionella pneumophila serogroup 1 strains isolated in Germany
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 541–542, https://doi.org/10.1093/jac/dkx386
Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 542–544, https://doi.org/10.1093/jac/dkx393
Emergence of multiple carbapenemase-producing organisms in single patients: an increasing threat to treatment of infection
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 544–546, https://doi.org/10.1093/jac/dkx411
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 546–548, https://doi.org/10.1093/jac/dkx385
Cytomegaloviraemia clearance with foscarnet during renal replacement therapy
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 548–549, https://doi.org/10.1093/jac/dkx398
Letter to the Editor
Comment on: Role of cephalosporins in the era of Clostridium difficile infection
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 2, February 2018, Pages 550–551, https://doi.org/10.1093/jac/dkx377
